Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1335139-13-3

C14H22N2O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1335139-13-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1335139-13-3 Structure

  • Basic information

    1. Product Name: C14H22N2O2
    2. Synonyms: C14H22N2O2
    3. CAS NO:1335139-13-3
    4. Molecular Formula:
    5. Molecular Weight: 250.341
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1335139-13-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C14H22N2O2(CAS DataBase Reference)
    10. NIST Chemistry Reference: C14H22N2O2(1335139-13-3)
    11. EPA Substance Registry System: C14H22N2O2(1335139-13-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1335139-13-3(Hazardous Substances Data)

1335139-13-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1335139-13-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,5,1,3 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1335139-13:
(9*1)+(8*3)+(7*3)+(6*5)+(5*1)+(4*3)+(3*9)+(2*1)+(1*3)=133
133 % 10 = 3
So 1335139-13-3 is a valid CAS Registry Number.

1335139-13-3Relevant articles and documents

CYCLOALKYL-SUBSTITUTED IMIDAZOLE DERIVATIVE

-

Paragraph 0223-0225, (2013/03/26)

A compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof, wherein A represents a C3 to C12 cycloalkyl group which may be substituted by one to three selected from a fluoro group, a hydroxy group, a C1 to C6 alkyl group, etc; R1, R2, and R3 each independently represent a hydrogen atom, a fluoro group, or a C1 to C6 alkyl group; R4 represents a hydrogen atom or a prodrug group; and Y represents -CH2-CHR5-CH2-NHR6 (wherein R5 represents a hydrogen atom, a C1 to C6 alkyl group, or a C1 to C6 alkoxy group, and R6 represents a hydrogen atom or a prodrug group), or the like exhibits excellent TAFIa inhibitory activity and is useful as a therapeutic drug for myocardial infarction, angina pectoris, acute coronary syndrome, cerebral infarction, deep vein thrombosis, pulmonary embolism, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1335139-13-3